This brand name is authorized in Austria, Australia, Cyprus, Germany, Estonia, Finland, Ireland, Lithuania, Netherlands, New Zealand, Turkey, United Kingdom, United States, South Africa
The drug ELOCON contains one active pharmaceutical ingredient (API):
1
Mometasone
UNII 04201GDN4R - MOMETASONE FUROATE
|
Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
ELOCON Cream, 0.1% | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
ELOCON Lotion, 0.1% | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
ELOCON Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
D07AC13 | Mometasone | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III) |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10791Y, 10792B, 10793C, 10804P, 10805Q, 10809X, 10812C, 10814E, 10815F, 10818J, 10819K, 10826T, 10827W, 10828X, 1913Q, 1915T, 4342M, 4343N, 8043H |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 07517031, 07517048, 07517054 |
Country: EE | Ravimiamet | Identifier(s): 1028933, 1028944, 1028955, 1061952, 1061963, 1061985, 1807219, 1807220, 1836165, 1842094, 1847101 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 000448, 116160, 116327, 116400, 116418 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 138709, 138711, 138715, 142177, 142180, 142185, 161710, 161711, 161713, 161715, 21394, 21402, 21403, 21408, 21412, 381325, 381326 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 22882, 22907, 23440 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1003000, 1003001, 1003003, 1088516, 1088517 |
Country: NL | Z-Index G-Standaard | Identifier(s): 14068478, 14068486, 14068494 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 46914, 63169, 63177 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 5957, 5958, 5959 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8683280337114, 8683280337121, 8683280337138, 8699636350294, 8699636350300 |
Country: US | FDA, National Drug Code | Identifier(s): 0085-0370, 0085-0854, 0085-3149 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): V/13.4.1/272, V/13.4.1/273, X/13.4.1/266 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.